PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.
Study Details
Study Description
Brief Summary
Iterative co-design study where patients receiving systemic cancer therapy, carers and healthcare professionals involved in delivering cancer therapy, work with Entia to design a home based blood monitoring service. The iterative process means that at each stage of the development process, Entia will be building on what is learnt in the previous stage.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The study will use feedback provided by patients, carers and heatlhcare professionals to inform the changes that are necessary to develop a successful, user friendly home-based blood monitoring service for cancer patients.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| HCPs Health care professional interviews (market research) |
Behavioral: Interviews
Focus group interviews
|
| Patients or caregivers Patients or caregivers interviews |
Device: Blood measurement and monitoring
Blood from a single fingerprick will be used to used to measure and monitor patients blood parameters.
Behavioral: Interviews
Focus group interviews
|
Outcome Measures
Primary Outcome Measures
- Qualitative capture of user feedback- focus groups [30 months]
Participant feedback on the iterative designs of a future home-based monitoring service in order to arrive at a final prototype device and service design, suitable for patient, carer and healthcare professional's use.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adequate english to participate in focus groups and workshops without an interpreter
-
Patients of the study site who are currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months
-
Patients willing to participate in at least 60-minute and ideally 90-minute workshops at the designated study location, time and date.
-
Patients capable of providing informed consent before attending the first workshop
For carers
-
Should be the primary carer nominated by a patient who fulfils the inclusion criteria, this includes parents of affected children
-
Should be willing to participate in at least a 60-minute and ideally 90-minute workshops at the designated study location, time and date.
-
Carers can only participate in the study with the cancer patient he/she is caring for. The patient has to also involved in the study
-
Carers need to be capable of providing informed consent before attending the first workshop
For healthcare professionals
-
All clinicians need to be current employees of the study site
-
Doctors need to be employed at Specialist Registrar, Fellow or Consultant Level
-
Nurses of all grades are invited to participate but ideally need to have had some involvement in the outpatient care of oncology patients
All participants:-
-
Should be willing to have the session's recorded audio, transcripts and analysed data from the focus groups/workshops shared with Entia Ltd.
-
should be willing to attend multiple 60 to 90 minute workshops.
-
should be willing for photos and video footage to be taken during the interview.
-
Participants attending workshops later in the development process must be comfortable consenting to finger prick testing/ assessing the ease of use of the test disposable
Exclusion Criteria:
For patients
-
Does not have adequate English to participate in focus group interview without an interpreter
-
Patients of the study site who are not currently undergoing systemic therapy or have previously undergone systemic therapy within the past 12 months
-
Patients not willing to participate in at least 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date.
-
Participant not capable of providing consent or have a suitable, legally acceptable representative present to provide consent before the focus group interview.
For carers
-
Is not the nominated primary carer of a cancer patient who fulfils the inclusion criteria, this includes parents of affected children
-
Not paired with a patient that is involved in the study
-
Carers not willing to participate in at least a 60-minute and ideally 90-minute focus group discussion at the designated study location, time and date.
For healthcare professionals
● Doctors who are not employed at Specialist Registrar, Fellow or Consultant Level
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | The Christie NHS Foundation Trust | Manchester | United Kingdom | M20 4BX |
Sponsors and Collaborators
- Entia Ltd
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRAS: 234137